MorphoSys's Licensing Partner GSK Shared Preliminary Results From...
Ad hoc: MorphoSys AG preliminary results for the fiscal year 2020...
MorphoSys AG: MorphoSys and I-Mab Announce First Patient Dosed in U.S....
MorphoSys and Incyte Announce Acceptance by Health Canada of the New Drug...
MorphoSys To Present At the 39th Annual J.P. Morgan Healthcare Conference
MorphoSys Appoints Sung Lee as Chief Financial Officer
MorphoSys and Incyte Announce the Acceptance of the Swissmedic Marketing...
MorphoSys AG: Corporate Calendar 2021
Data Evaluating Tafasitamab with and without Lenalidomide in Combination...
MorphoSys' Licensee Announces Approval by the European Commission for...